ArticleJournal of medicinal chemistry2021

Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer.

Yali He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.